Related Experiment Video
Updated: May 14, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Folate fortification and supplementation do not provide vascular health benefits in type 1 diabetes
Alexia Sophie Peña1, Oana Maftei, Kate Dowling
1Department of Pediatrics, University of Adelaide, Adelaide, South Australia, Australia. alexiasophie@yahoo.com
Insights
Mandatory folate fortification improved folate status and vascular function in children with type 1 diabetes. Additional folic acid supplementation did not further enhance endothelial function in these children.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Health
- Nutritional Science
Background:
- Type 1 diabetes is associated with endothelial dysfunction.
- Mandatory folate fortification in Australia may impact folate status and vascular health in children.
- Previous studies suggested a potential benefit of folic acid on endothelial function.
Purpose of the Study:
- To determine the lowest effective dose of folic acid for improving endothelial function in children with type 1 diabetes.
- To assess the dose-response relationship of folic acid supplementation on endothelial function.
- To compare endothelial function in children with type 1 diabetes before and after mandatory folate fortification.
Main Methods:
- Randomized, double-blind, crossover, placebo-controlled trial.
- 20 children with type 1 diabetes received folic acid (0.5, 2, 5 mg) or placebo.
- Endothelial function assessed by flow-mediated dilatation (FMD) 2 hours post-intervention.
Main Results:
- Folic acid supplementation increased serum and red blood cell folate levels.
- No significant improvement in flow-mediated dilatation (FMD) was observed with any folic acid dose.
- Children post-fortification had significantly higher baseline folate levels and improved vascular function compared to pre-fortification.
Conclusions:
- Mandatory folate fortification has improved folate status and endothelial function in children with type 1 diabetes.
- Additional folic acid supplementation does not provide further endothelial benefits in this population.
- The established folate status likely saturates the beneficial effects of folic acid on vascular function.
Objective:
To evaluate the lowest effective dose-response of folic acid on endothelial function in children with type 1 diabetes.
Study Design:
A randomized, double-blind, crossover, placebo-controlled trial was conducted in 20 children with type 1 diabetes (age range 10-18 years) after mandatory folate fortification in Australia. Each child received orally 4 interventions (1 per month)-3 folic acid doses (0.5, 2, and 5 mg) and 1 placebo dose--in random order. The primary outcome was 2-hour postintervention change in endothelial function measured with flow-mediated dilatation (FMD). Thirty-five children with type 1 diabetes from our folic acid interventional trial before folate fortification were used for comparison.
Results:
All children completed the study. There were no differences in baseline FMD or folate status between the visits. Folic acid supplementation increased serum folate (P = .0001) and red cell folate (P < .0001), but none of the doses improved FMD (P = .96). Baseline serum folate and red cell folate levels and FMD and glyceryl trinitrate-mediated dilatation were significantly higher in these children compared with children from our trial before mandatory folate fortification (P = .0001, .0001, .014, and .04, respectively).
Conclusions:
Folate status and vascular function have improved in children with type 1 diabetes since the introduction of mandatory folate fortification, but the beneficial endothelial effects of additional folic acid are no longer present.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Vitamins
Type I Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction

